Azzet reports on three stocks with price moving updates today.
4DMedical slumps on capital raise update
The market took little time to decide what it thought of 4DMedical’s (ASX: 4DX) market update this morning, with the share price down around 4% after trading resumed following its trading halt on Tuesday.
Trading resumed after the respiratory imaging technology large capitalisation stock told the market it had secured $150 million in an institutional placement, supported by new global long-only investors and strong demand from existing shareholders.
Divided between $79.1 million of new shares and a $70.9 million block trade, the raisinge limits dilution to 3.86% by repurposing shares previously issued to Alpha Investment Partners.
It is understood the proceeds will be used first and foremost to advance the commercialisation of its CT:VQ lung imaging technology across U.S. academic medical centres, including Stanford, Cleveland Clinic, University of Miami, and UC San Diego Health.
4DMedical founder and CEO Andreas Fouras told the market the placement – which adds high-quality global institutional investors to the share register - strengthened the balance sheet strength to accelerate U.S. commercialisation of CT:VQ.
Fouras was also quick to flag unprecedented interest from clinicians was driving rapid adoption across leading academic medical centres.
“Since FDA clearance, adoption by elite institutions such as Stanford, Cleveland Clinic, University of Miami and UC San Diego has validated both our technology and our go-to-market strategy,” Fouras said.
"With a strong commercial pipeline ahead of us, strategic partnerships including Philips, and now a cash position exceeding $200m, we have the resources to drive CT:VQ to become the new standard in pulmonary imaging while taking the company through profitability and to the next set of opportunities.”
What the market did not like about the placement - resulting in the issue of 20,806,185 shares - was the $3.80 per share issue price, which represented an 11.4% discount to its last closing price of $4.29.
Investors should note that the 18,667,500 Block Trade shares were previously issued to Alpha Investment Partners as collateral pursuant to a funding facility entered into between the Company and Alpha, as announced to market on 28 June 2024.
These shares have been repurposed to be issued as part of the institutional placement.
All funds received for the Block Trade of the shares previously issued to Alpha will be paid to the company (net of transaction costs) and applied to the use of proceeds described above.
No proceeds from the Block Trade will be paid to Alpha.
The company’s pro forma cash position will exceed $200 million, providing flexibility to expand its product portfolio, fund operations, and pursue growth opportunities toward profitability.
Settlement of the placement is expected on 21 January with trading of the new and block trade shares commencing on 22 January.
As 4DMedical’s shares have run up more than 700% over the past 12 months, the stock appears destined to enter the ASX 200 when it rebalances in March 2026.
4DMedical has a market capitalisation of $2.2 billion; the share price is up 86% in the last month.
The stock appears to be in a strong bullish trend confirmed by multiple indicators.
The consensus recommendation is Strong Buy.
Neometals soars after updating on Barrambie gold
Shares in Neometals (ASX: NMT) were trading 15% higher at noon after the junior explorer reported all gold assay results from recent reverse circulation drilling at the Ironclad deposit and historic Mystery mine area within its 100%-owned Barrambie Gold Project in WA.
The results reinforced Barrambie’s potential as a significant gold development alongside its titanium resource and underpin Neometals’ transition toward production, including its planned joint venture with BML Ventures.
The miner confirmed a series of strong gold intercepts from recent reverse circulation (RC) drilling, confirming continuity and depth potential at the Ironclad deposit and the historic Mystery mine area.
Highlights at Ironclad included broad, high-grade intervals such as 26m at 4.04g/t gold from surface and 19m at 4.16g/t, supporting the interpretation of a wide stockwork zone and a northerly plunging high-grade core that remains open at depth.
Meanwhile, at Mystery, drilling returned 14m at 11.74g/t gold, reinforcing the presence of a high-grade plunging structure below historic workings.
The company has begun updating the Ironclad mineral resource estimate and mine plan, with supporting technical studies under way ahead of mining approvals, positioning Barrambie’s gold potential as a near-term development pathway alongside its titanium assets.
Commenting on today’s results, Neometals managing director, Chris Reed told the market that new drill data provides further confidence in the Barrambie Gold Project as it transitions to the development of the Ironclad deposit.
“We have commenced the process for updating the mineral resource estimate and mine planning for the Ironclad Deposit, including with regard to Neometals’ LOI for a production joint venture with BML Ventures as announced in December 2025.”
The Barrambie Project hosts one of the world’s highest-grade titanium deposits and is also highly prospective for gold mineralisation.
Based on this extensive exploration dataset, in 2024 the Company announced an exploration target between 8Mt at an average grade of 1.3g/t Au and 10.5Mt at an average grade of 2.3g/t Au, for an implied 335k to 775k ounces4, outlining the potential of the Barrambie Project to host multiple gold occurrences.
Today’s update follows revelations yesterday that Neometals and Mineral Resources 70:30 joint venture company, Reed Advanced Materials, had inked a three-year collaboration agreement with Italy’s Industrie De Nora and De Nora’s Japanese subsidiary, De Nora Permelec.
De Nora is the world's largest manufacturer of insoluble electrodes, including anodes, cathodes and catalytic coatings.
It is a recognised global leader in electrochemical technologies, which include its CECHLO electrolysis solutions, which the company will integrate with RAM's patented ELi Process.
Neometals has a market capitalisation of $56 million; the share price is down 8% on one year and up 35% in the last month.
Sentiment among investors may be improving.
The weak trend in the 200-day moving average shows sellers were more aggressive than buyers for quite some time.
More recently, the demand/supply equation has come into balance and the stock has shown little in the way of a confirmed trend.
There is no consensus recommendation for this stock.
BHP rallies on plans to mine Pilbara iron ore with Rio
Longsuffering BHP (ASX: BHP) shareholders were glowing this morning after the big miner’s share price moved 3% higher bringing within cooee of the all-important $50 milestone.
Although the stock has rallied 8% since the year started on the back of record prices for key metals – notably copper, silver, platinum and gold – today’s share price kicker appears to be linked to its announced plans to partner with rival Rio Tinto (ASX: RIO) to mine Pilbara iron ore.
The company released these plans on its website without posting them to an ASX update.
In a short post on its website yesterday, BHP disclosed that it ha agreed with Rio Tinto to work together to extract up to 200 million tonnes of iron ore at their neighbouring Yandicoogina and Yandi iron ore operations in the Pilbara.
Under two non-binding Memoranda of Understanding (MOUs), the companies will explore the potential for:
• Collaboration on the development of Rio Tinto’s Wunbye deposit; and
• BHP to supply its Yandi Lower Channel Deposit ore to Rio Tinto for processing at its existing wet plants under agreed commercial terms.
These new opportunities build on a 2023 agreement between Rio Tinto and BHP to mine the Mungadoo Pillar, which allowed mining of ore from the shared tenure boundary that was previously inaccessible.
Rio Tinto iron ore CEO Matthew Holcz told the market that by working smarter, they could better leverage infrastructure to unlock additional production with minimal capital requirements.
“Together we will extend the life of these operations, create additional value, and further support Western Australian jobs and local communities,” Holcz said.,
Meanwhile, BHP WA Iron Ore Asset President Tim Day described the deal as a clear example of productivity in action – unlocking new opportunities by making the most of our existing resources.
“By sharing our expertise and infrastructure we will create new value and deliver benefit to our people, partners, customers and communities."
Rio Tinto and BHP have agreed to progress a conceptual study followed by an order of magnitude study. Subject to a final investment decision, first ore from both deposits is anticipated early next decade.
Any potential implementation would be subject to regulatory and joint venture approvals, and engagement with Traditional Owners.
BHP has a market capitalisation of $251 billion; the share price is up 24% in one year.
Although the share price has struggled to regain the $50 it reached in December 2023, it appears to be in a strong bullish trend confirmed by multiple indicators.
Specifically, a five-day moving average of the stock price is above the 50-day moving average.
Additionally, the 200 and 20-day moving averages are trending higher.
The consensus recommendation is Moderate Buy.
This article does not constitute financial or product advice. You should consider independent advice before making financial decisions.
